1. What is the name of the researcher who worked with Dr. Liu to develop the base editing system, and who is now leading the effort to apply this technology to human patients with progeria?

2. What is the expected timeline for the FDA to approve the base editing system for use in human patients with progeria, assuming the clinical trial is successful?